secwatch.observer — SEC 8-K summary
======================================

Issuer:     CODEXIS, INC. (CDXS)
CIK:        0001200375
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001193125-25-039264
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Codexis FY2024 revenue $59.3M, net loss $65.3M; guides 2025 revenue $64M-$68M
-----------------------------------------------------------------------------

- FY2024 total revenue $59.3M (-4% YoY ex-PAXLOVID); net loss $65.3M ($0.89/share) vs $76.2M ($1.12) in FY2023.
- Q4 total revenue $21.5M (+17% YoY ex-PAXLOVID); net loss $10.4M ($0.13/share) vs $7.2M ($0.10) in Q4 2023.
- Guides FY2025 total revenue $64M-$68M (double-digit growth); expects path to cash flow positivity by end of 2026.
- Cash, cash equivalents and short-term investments $73.5M at Dec 31, 2024; raised $31M via ATM in Sep 2024.
- Appointed Arthur Levin to Strategic Advisory Board; expects first ECO Synthesis contract in H1 2025 and GMP scale-up partner by end of 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1200375/000119312525039264/0001193125-25-039264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1200375/000119312525039264/d832121d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-039264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer